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Purpose of the study
To evaluate the prevalence of respiratory symptoms and
COPD in a stable HIV-infected outpatient population
and to further investigate the role of HAART and other
possibly associated risk factors.
Methods
All participants completed a questionnaire for pulmon-
ary symptoms and the MRC dyspnoea scale. A complete
spirometry with evaluation of the residual volume was
performed using the bodyplethismographic method. We
considered the Total Lung Capacity (TLC), Forced
Expiratory Volume (FEV1) at 1st second and the FEV1/
FVC ratio (Tiffenau Index) for each patient.
Summary of results
We enrolled 111 HIV-infected patients with a mean age
of 42.3 ± 8.1 years and 65 HIV-negative age and sex-
matched controls. Seventy-seven (69.4%) HIV patients
were male and 39 (35.1%) were in CDC stage C. Eighty-
seven (78.4%) were receiving HAART. Mean CD4 cell
count was 541 ± 243 cells/mm
3 and 79 (71.2%) had an
undetectable HIV-RNA. Sixty-three (56.8%) patients were
active smokers whereas 48 (43.2%) were non-smokers.
No significant difference in age, sex, proportion of smo-
kers and pack-year history of smoking was evidenced
between HIV positive patients and controls. However,
HIV-infected individuals had significantly lower FEV1
(p=0.002) and FEV1/FVC (p=0.028), whereas TLC was
significantly higher (p=0.018). Furthermore, HIV-infected
patients had a significantly higher proportion of any
respiratory symptom (p=0.002), cough (p=0.006) and dys-
pnoea (p=0.020). HIV-infected patients had also a signifi-
cantly (p=0.008) higher proportion (23.4%) of COPD in
respect of HIV-negative controls (7.7%). In a multivariate
regression analysis significant predictors of respiratory
symptoms were current smoking (AOR 11.18; 95% C.I
3.89-32.12) and previous bacterial pneumonia (AOR 4.41;
95% C.I. 1.13-17.13), whereas the only statistically signifi-
cant predictor of COPD was current cigarette smoking
(AOR 5.94; 95% C.I. 1.77-19.96). HAART receipt was not
significantly associated with respiratory symptoms nor
with COPD.
Conclusions
Our results suggest a role for HIV infection itself and for
current cigarette smoking in the development of respira-
tory symptoms and COPD in HIV-infected patients.
HAART did not seem to reduce the risk of respiratory
symptoms and COPD, in our cases. Thus, our results
suggest that HIV-infected patients should be screened for
chronic respiratory disease in order to early identify those
at risk or those who need specific treatment.
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